2018
DOI: 10.1016/j.jisp.2018.10.004
|View full text |Cite
|
Sign up to set email alerts
|

Functional and Mechanistic Insights into the Pathogenesis of P63-Associated Disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…p63, a homolog of the well‐known tumor suppressor p53, contains several variant isoforms including the contain transactivation domain (TAp63) and the lack transactivation domain (ΔNp63) 72 . TAp63 acts as a tumor suppressor, but ΔNp63 is an oncoprotein 73 .…”
Section: Emt‐inducing Transcription Factorsmentioning
confidence: 99%
See 1 more Smart Citation
“…p63, a homolog of the well‐known tumor suppressor p53, contains several variant isoforms including the contain transactivation domain (TAp63) and the lack transactivation domain (ΔNp63) 72 . TAp63 acts as a tumor suppressor, but ΔNp63 is an oncoprotein 73 .…”
Section: Emt‐inducing Transcription Factorsmentioning
confidence: 99%
“…29,71 4.4 | ΔNp63 p63, a homolog of the well-known tumor suppressor p53, contains several variant isoforms including the contain transactivation domain (TAp63) and the lack transactivation domain (ΔNp63). 72 TAp63 acts as a tumor suppressor, but ΔNp63 is an oncoprotein. 73 Recent studies indicated that ΔNp63 is involved in tumor progression, because its upregulation is associated with the tumor grade and advanced stage in various types of squamous cell carcinoma include OSCC.…”
Section: Zeb Familymentioning
confidence: 99%